HAEMONETICS CORPORATION
NYSE: HAE (Haemonetics Corporation)
Last update: 7 hours ago79.96
0.55 (0.69%)
| Previous Close | 79.41 |
| Open | 79.33 |
| Volume | 322,076 |
| Avg. Volume (3M) | 559,403 |
| Market Cap | 4,015,902,976 |
| Price / Earnings (TTM) | 33.18 |
| Price / Earnings (Forward) | 14.88 |
| Price / Sales | 2.90 |
| Price / Book | 4.38 |
| 52 Weeks Range | |
| Earnings Date | 6 Feb 2025 |
| Profit Margin | 9.10% |
| Operating Margin (TTM) | 16.44% |
| Diluted EPS (TTM) | 2.41 |
| Quarterly Revenue Growth (YOY) | 8.60% |
| Quarterly Earnings Growth (YOY) | 35.80% |
| Total Debt/Equity (MRQ) | 149.62% |
| Current Ratio (MRQ) | 3.49 |
| Operating Cash Flow (TTM) | 84.94 M |
| Levered Free Cash Flow (TTM) | 85.98 M |
| Return on Assets (TTM) | 5.88% |
| Return on Equity (TTM) | 13.97% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Bullish | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Haemonetics Corporation | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | -4.0 |
| Average | -0.50 |
|
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Core |
| % Held by Insiders | 0.89% |
| % Held by Institutions | 113.64% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Neuberger Berman Group Llc | 30 Sep 2024 | 4,027,103 |
| Royce & Associates Lp | 30 Sep 2024 | 1,210,546 |
| Thrivent Financial For Lutherans | 30 Sep 2024 | 1,100,183 |
| Schroder Investment Management Group | 30 Sep 2024 | 937,289 |
| Westfield Capital Management Co Lp | 30 Sep 2024 | 823,663 |
| Boston Trust Walden Corp | 30 Sep 2024 | 809,608 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 120.00 (Raymond James, 50.08%) | Buy |
| Median | 114.00 (42.57%) | |
| Low | 108.00 (Barrington Research, 35.07%) | Buy |
| Average | 114.00 (42.57%) | |
| Total | 4 Buy | |
| Avg. Price @ Call | 84.35 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JP Morgan | 06 Dec 2024 | 116.00 (45.07%) | Buy | 81.19 |
| Barrington Research | 04 Dec 2024 | 108.00 (35.07%) | Buy | 83.51 |
| 08 Nov 2024 | 108.00 (35.07%) | Buy | 87.42 | |
| Needham | 03 Dec 2024 | 112.00 (40.07%) | Buy | 85.26 |
| 15 Nov 2024 | 112.00 (40.07%) | Buy | 89.22 | |
| Raymond James | 08 Nov 2024 | 120.00 (50.08%) | Buy | 87.42 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 14 Jan 2025 | Announcement | Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A |
| 08 Jan 2025 | Announcement | Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025 |
| 06 Jan 2025 | Announcement | Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference |
| 03 Dec 2024 | Announcement | Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A |
| 07 Nov 2024 | Announcement | Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |